AFYREN: insider trades · France · AMF

About AFYREN

AFYREN is a French greentech company focused on biosourced chemistry and biomass valorization through fermentation. Listed on Euronext Growth Paris since 2021 under ISIN FR0014005AC9 and ticker ALAFY, the company develops a proprietary industrial technology designed to produce renewable organic molecules that can replace petrochemical ingredients. Its positioning sits at the intersection of the circular economy, decarbonization and the transition toward lower-carbon industrial inputs. Founded by teams with a background in science and industry, AFYREN built its business model around a breakthrough process based on natural microorganisms. Using fermentation, it converts non-food biomass by-products into organic acids and other high-value molecules. The company emphasizes a zero-waste logic and a regenerative, green-chemistry approach. A key commercial advantage is that its solutions are designed to be plug-and-play for industrial customers, allowing them to adopt more sustainable ingredients without having to materially redesign their production processes. AFYREN’s first industrial asset, AFYREN NEOXY, is a biorefinery located in the Grand Est region of France and primarily serves the European market. In 2025, the company took full control of this plant, an important milestone that strengthened its industrial and operational oversight. Beyond France, AFYREN is also advancing an industrial project in Thailand with a major sugar industry player and is expanding its commercial footprint in the Americas through existing distribution agreements. The company targets several strategic end markets: human and animal nutrition, flavors and fragrances, life sciences, materials science, lubricants and technical fluids. This diversification broadens its addressable market and supports the relevance of its platform technology across multiple downstream industries. At the end of 2025, AFYREN employed 140 people across Lyon, Clermont-Ferrand and Carling Saint-Avold, and it dedicated about 20% of its annual budget to R&D, underlining a strongly innovative and capital-intensive profile. Overall, AFYREN is emerging as a notable French player in sustainable chemistry, combining proprietary technology, industrial scale-up and international growth ambitions.